Skip to main content
. Author manuscript; available in PMC: 2023 Apr 1.
Published in final edited form as: Eur Respir J. 2021 Sep 24;59(4):2101649. doi: 10.1183/13993003.01649-2021

Table 5.

Neurocognitive impairment results in randomized clinical trial on the effect of CPAP in exclusively elderly series

Study (RCT) n Age CPAP vs no-CPAP
Digit Span Digit Symbol test HADS depression HADS anxiety TMT-A TMT-B
Aloia et al(145) 12 64.8 ± 4.7 - 5.74 (C95%, 1.69 - 9.79), p<0.001 - - - 1.8–48.0 (6.8 <0.05
Dalmases et al(142) 33 71.3 ± 5.5 0.79 (CI95%,−0.30, 1.88), N.S 5.74 (CI95%,1.69, 9.79), p<0.01 −0.42 (CI95%:−1.84, 0.99), N.S −0.43 (CI95%:−1.0, −1.88), N.S −2.68 (CI95%:−16, 10.6), N.S −47.64 (CI95%:−81.8, −13.4), p<0.01
Mc Millan et al(140) 278 71.1 - 1.1 (CI95%,−0.6, 2.7) N.S. −0.4 (CI95%: −1.0, 0.3); N.S −0.2 (CI95%: −0.9, 0.5); N.S - 6.2 (CI95% −3.4, 15.8); N.S
Martinez-Garcia et al(139) 224 75.5 ± 3.9 −0.08 (CI95%, −0.55, 0.4; N.S −1.43 (CI95%, −2.84, −0.02); p<0.05. 1.98 (CI95%: 1.18-2.7), p<0.001 1.19 (CI95% 0.22-2.16); p=0.016 10 (−4–34) versus 0 (−16–11); p=0.029) −9.4 (95% CI −24–5.3) N.S
Ponce et al(141) 145 74.9 ± 4.6 −0.2 (CI95%, −0.6, 0.9); NS −0.9 (CI95%, −2.5, −4.3) N.S 0.2 (CI95%, −0.9, −0.5), N.S 0.8 (CI95%, 0.2–1.7), N.S −5.6 (CI95%, −14.3–3), N.S −9.4 (95% CI −24–5.3). p<0.05
Richards et al(146) 54 70.1 ± 8.3 - 1.68 (CI95%:0.73-2.62), p<0.05 - - - -

HADS: Hospital Anxiety and Depression Scale; TMT: Trail making Test; CPAP: Continuous positive airway pressure, CI: Confidence interval; RCT: Randomized controlled trail.